follow @RheumNews
RSS Feeds
Find Us on Facebook

Lupus/Connective Tissue Diseases

Ondansetron Quells Methotrexate-Induced Nausea

By: BRUCE JANCIN, Rheumatology News Digital Network

01/04/12

EXPERT OPINION FROM THE ANNUAL CONGRESS OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Bookmark and Share


Submitting your vote...
Not rated yet. Be the first who rates this item!
Click the rating bar to rate this item.

LISBON – Getting an earful of complaints of nausea from your patients on oral methotrexate therapy?

Consider bracketing the antifolate drug with the antiemetic ondansetron before and afterward, Dr. Richard B. Warren suggested at the congress.


Dr. Richard B. Warren

 

"One successful means of helping patients overcome their nausea that we’ve used a lot in Manchester is ondansetron. For some people it can literally sort out the nausea altogether," said Dr. Warren, senior lecturer and honorary consultant dermatologist at the University of Manchester (England).

The dosing is 8 mg of ondansetron (Zofran) – a serotonin receptor antagonist used to treat nausea caused by chemotherapy, radiation therapy, and/or surgery – administered 2 hours before and once again 12 hours after taking methotrexate.

Nausea is a common nuisance side effect of the drug. It affects roughly one-quarter of patients, typically beginning about 12 hours after they take their weekly dose. The nausea can last for up to 72 hours.

In addition to prophylactic ondansetron, other strategies that may be effective in overcoming methotrexate-induced nausea include the following:

– Divide the dose.

– Have patients take their oral methotrexate with the evening meal.

– Consider switching to subcutaneous methotrexate. "It has been shown to be more efficacious, and with less in the way of adverse events than oral methotrexate," Dr. Warren said.

He declared having no relevant financial interests.

> more Connective Tissue Diseases articles


Sign-up to receive the Rheumatology e-newsletter
I would like to receive Rheumatology News E-Newsletter each week.


Specialty Focus
Sponsored by


calendar
Jun 6 - 9
Berlin,
EULAR (European League Against Rheumatism): 2012 Congress
Aug 23 - 25
San Francisco, CA
University of California, San Francisco (UCSF): Rheumatology Board Review and Clinical Update
Sep 2 - 5
Copenhagen,
Scandinavian Congress of Rheumatology (SCR)
Sep 28 - 29
Newport Beach, CA
5th Annual Perspectives in Rheumatic Diseases presented by Rheumatology News, Internal Medicine News & Family Practice News
Nov 9 - 14
Washington, DC
American College of Rheumatology (ACR): Annual Scientific Meeting
Nov 14 - 17
Prague,
Connective Tissue Oncology Society (CTOS): Annual Meeting
Jan 26 - Feb 1
,
American College of Rheumatology (ACR): Winter Rheumatology Symposium
Feb 6 - 9
Maui, HI
Rheumatology Winter Clinical Symposium 2013
Feb 13 - 16
Ottawa,
Canadian Rheumatology Association (CRA): Scientific Conference and Annual General Meeting
Sep 21 - 25
Natal,
11th World Congress on Inflammation
More Calendar »